Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Either is the last 100 virus listings LOL
Researcher 'on verge of making very significant' coronavirus findings shot to death
TODAY May 5, 2020, 10:03 PM CDT
A medical researcher said to be on the “verge of making very significant” coronavirus findings was found shot to death over the weekend in Pennsylvania, officials said.
Bing Liu, 37, a researcher for the University of Pittsburgh School of Medicine, was found dead Saturday inside a home in Ross Township, north of Pittsburgh, the Allegheny County Medical Examiner said.
https://www.yahoo.com/news/researcher-verge-making-very-significant-030320409.html
Great virus video
Holdthebag
So you made your point - what would you like to do or have me do about it
NOTHING --- There's nothing to do --- I'm not selling because she extending her warrants for nothing
Any suggestions since you brought it up ????
We don't need a short position - waste of time talking about it
All we need is our DATA -- The rest will take care of itself
And Warrants although recent - Who Cares
Again All we need is our data !
We been here so long -- again -- All we need is our data
Complaining about the past is like complaining about an old girl friend
PERIOD
Don't Make Me Leak
What? NO DILUTION ON A FRIDAY NIGHT !!!
You have some time left tonight -- or you will be so disappointed
All you dudes know who you are.
Many years ago there was a person that received DCVAX and talked about that exact subject. She mentioned that she noticed that she did not even get sick during the winter anymore.
It was on another message board dealing with cancer patients.
Can't remember which one ---- I was young when this started out
Now ? I question myself all the time
Don't Make Me Leak
Merck (NYSE:MRK) announced on April 28 that the U.S. Food and Drug Administration (FDA) had granted accelerated approval for a new treatment schedule for its marquee cancer drug, Keytruda. For context, Keytruda posted $11.1 billion in sales last year. Its closest competitor, Opdivo from Bristol Myers Squibb (NYSE:BMY), generated $7.2 billion in 2019 sales. The stakes are high for these blockbuster drugs, which have changed the cancer treatment landscape in recent years.
Come on Merck - we can steal that 7.2 billion market from Bristol Myers
Together !!!!!!!
Duffy Let Roll !!
Don't Make Me Leak
Didn't know we had 600,000 deaths from the virus ??
Anyone know where that number came from ? he he he he
OK - Its been so long maybe I just forgot about the combo thing ....
Its been a long road .....
Temozolomide plus the vaccine OK
Let's Go
For everyone that thinks we will get more dilution and the price will fall - Who Cares - I will be BUYING
I also like to state that if a person survives 3 to 5 years even 2 don't you think they would just go through the process again??
Get the antigens and create another vaccine?
Do you think people will just give up? No way
- I'm talking more than GBM
Especially 5 year survivors ------
5 years is a long time - so its a cure in my view
Im not even addressing the extra revenue - just talking surviving
I don't think the combo is old news ?? Correct me if Im wrong ...
Here, the researchers announced results of their PhaseIII trial where an autologous tumour-lysate-pulsed Dendritic Cell Vaccine ((DCVax ® -L) was added to the standard programme. In this study after surgery patients received either Temozolomide plus the vaccine, or Temozolomide plus a placebo.
When did the combo start ??
Temozolomide plus the vaccine ????
I'll just wait for our experts to respond - Lucky to have them
Hope4 - your one of them
Give Beartrap both days - it doesn't matter because I have the correct day.
Yea baby start the trash talking
Maybe - But if its part of the plan lets GO!
Get it done - and the new stock or whatever it will be will start to move up quicker then what has happen the last 10 years . Exaggeration OK
HEY - I'm following the DCVAX - Where ever it goes I GO.
DCVAX will make someone the King or Queen of Cancer Care!!!!!
Not looking to stop at a few dollars but a few dollars will give me all I ever looked for. And Able to help others
My order at .17 is slowly being filled----- Still a little ways to go
There is more than 1 way for those warrants to expire or a reason to be executed early.
What if this company merged with all/some involved with DCVAX?
New Stock Symbol ????
I'm going to detail the companies- you all know who they are or can be ..
Nothing is for sure
Is this a joke? ---- OMG ---- Let's Roll and Save Some Lives
1.7 Months ? Take Two Aspirin and call me in the morning ----
I must be missing something ...... Help Me Out
The FDA-mandated EF-19 post-approval registry trial studied Optune as a monotherapy for the treatment of recurrent GBM in 192 patients compared to the 117 recurrent GBM patients who received best standard of care chemotherapy in Novocure's EF-11 registration trial. Optune as monotherapy reduced the risk of death with fewer adverse events compared to best standard of care chemotherapy. For patients who received at least one course of therapy, Optune prolonged survival by a median 1.7 months. No new safety signals were noted. The EF-19 data confirm the effectiveness and safety of Optune as monotherapy and further strengthen Optune's clinical profile in recurrent GBM.
NovoCure announces presentation of EF-19 post-approval registry trial data studying optune as a monotherapy for the treatment of recurrent GBM at the American Association for Cancer Research 2020 Virtual Annual Meeting NVCR
Marzan - How do you like that trade for 143,999 shares at the ask.
.18
Trading does look a little different today. Will it stay ? Who Knows
Well Yesterday there was many trades at the ask also so I might retract that previous statement .....
Shorters are waiting for the buyers to slow down before they throw their money at us. Someday soon it will bite them in the (you know what) LOL
Let's see how the volume goes for the reminder of the day.
A true waited amount of disk space to save that post on IHUB
Did anyone see/post today's alert from Micro Cap Daily
I like the fact that they mentioned DCVAX Direct.
Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) held its annual shareholder virtually this year due to covid-19 and CEO Linda Powers, discussed the projected schedule for reaching data lock, unblinding and reporting of top line data from its 331-patient Phase 3 trial of DCVax®-L for Glioblastoma brain cancer.
According to NWBO CEO Linda Powers “the current estimate of public disclosure of top line data would range from the end of June to early July.
Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) is a clinical stage biotechnology company focused on the development of personalized immunotherapy for a broad range of solid tumor cancers. The company has over 190 issued patents and more than 65 pending patent applications worldwide, grouped into 12 patent families. The Company is led by Linda Powers, a successful entrepreneur who worked for many years in corporate finance and restructurings, mergers and acquisitions, joint ventures and intellectual property licensing. Ms. Powers has served as the Chairman of NW Bio since 2007, and as CEO since 2011.
NWBO platform technology is DCVax, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. Northwest lead product is DCVax-L for Glioblastoma multiforme (“GBM”), the most lethal form of primary brain cancer. The Company has completed two Phase I/II trials and are now well under way with a large Phase III trial, as described below. Northwest is currently conducting a 348-patient double blind, randomized, placebo controlled Phase III clinical trial with DCVax-L for newly diagnosed GBM. The primary endpoint of the trial is “Progression Free Survival,” meaning the length of time that a patient continues without disease progression (i.e., recurrence of the tumor). Secondary endpoints include overall survival and other measures. The trial is under way at 51 sites (medical centers) across the US. The sites and the eligibility criteria are listed in the profile of the trial at ClinicalTrials.gov. The trial is also under way in Europe. The lead site is Kings College Hospital in London. Approximately 30 trial sites are also in varying stages of preparation in the U.K. and Germany.
DCVax® – Direct offers a potential new treatment option for the wide range of clinical situations in which patients’ tumors are considered “inoperable” because the patient has multiple tumors, or their tumor cannot be completely removed, or the surgery would cause undue damage to the patient and impair their quality of life. DCVax-Direct is administered by direct injection into a patient’s tumors. It can be injected into any number of tumors, enabling patients with locally advanced disease or with metastases to be treated. DCVax-Direct can also be injected into tumors in virtually any location in the body: not only tissues at or near the surface of the body but also, with ultra-sound guidance, into interior tissues. Northwest is currently conducting a 60-patient Phase I/II trial of DCVax-Direct for all types of inoperable solid tumors. The trial is under way at MD Anderson in Houston, TX and MD Anderson in Orlando, FL, with additional sites in varying stages of preparation. The Phase I stage of the trial involves dose escalation, testing 3 different dose levels of DCVax-Direct, and confirmation of the optimal dose.
DCVax®-Prostate is designed specifically for late stage, hormone independent prostate cancer. Such cancer involves the spread of micro-metastases beyond the prostate tissue. In most patients, there is no focal tumor which can be surgically removed and used to make lysate, or into which dendritic cells can be directly injected. Instead, the cancer cells are diffuse. We have developed a DCVax product line using a particular proprietary antigen — PSMA (Prostate Specific Membrane Antigen) — which is found on essentially all late stage (hormone independent) prostate cancer. The PSMA is produced through recombinant manufacturing methods, and is then combined with the fresh, personalized dendritic cells to make DCVax-Prostate.
Whats with all the 4999 trades at the ask today I'm seeing 12 in the last few minutes
July 21 if open if not July 22 if Not July 23
Any thought to when Duffy came over?
The two months when everything stopped because of the virus .
Yes - Everything stopped at North-West BIO - as far as Trials
And
Yes - Everything stopped at Merck - as far as Trials
Great Time to get closer to a company that you are interested with.
And by the way things just didn't stop on a certain date.
Merck is smart enough to see the hand writing on the wall and make plans
Like the timeline.
I can tell you that the two hospitals that my children work in,, visitors are not allowed in. Even the Wife's or Husbands of patients unless near an event( could not resist)
So I know its true that the people finalizing the data could not get into the hospitals.
Overall - very good timeline , just wish they would of answered more questions
Explanation of meeting agenda does not sound good
Well have to wait and see
I went in as a guest after number was rejected
Music plays for 15 -- you can restart music by clicking the play line
Scolling music line. fyi
Going to make me an Irish Coffee before we start
You can login to the meeting now and listen to the music.
Just in Case there is a limit or whatever.
Music is calming and I need it LOL
I think I'm leaking
Its all over but the crying
The question is: Who will be crying
Im ready to leak
Not the best article but here you go.
My son says there are better ones on the net.
https://pubmed.ncbi.nlm.nih.gov/32252338/
Son is a Pharmacist ---- He gives me this equator talk
Everyone above the equator is low on Vit D
I take 4000iu a day ---- Labs had me at 0 once
After prescription now 4000
Why talk about the Price of the stock back 5 years ago.
If that was important then people including me would of sold a long time ago. Its meaningless .........
I prefer to look to the future price.
OK - This is where I try to be fair to you...
That future price might be lower or Higher but Im hear to find out and when I do I might make adjustments or just watch it climb up as the company expands to multiple countries.
So you can continue to talk about what has happen in the year 2000 but I'll keep thinking about what will happen come Monday Morning ....
Good Luck to you and yours
Either way your job will be completed here and you will move on
Have a Great Day and Be Safe
Exactly - We are saying the same thing
Because of DCVAX everyone is living longer
I don't know how the FDA will look at this but I'm delighted that
the people that went into the trial are living longer because of DCVAX.
Maybe the FDA will not like this but come on. Are you telling me the FDA would deny a treatment because to many people are living longer than
expected.
The Trial did fail because we didn't have enough deaths.
Now Im going to hit my head to the wall for 20 minutes
WOW ---
Yes Scotty -- we need some people to die - pass away --- event
yes then we can make more money and get the treatment in the public sooner
Yes the trial failed because they did not die.......
Her entire quote is exactly what Tilt is implying.
That's what I get out of the entire quote....
There would be more events if the Placebo arm didn't come over and get their DCVAX treatment.
In other words we would be better off if more people died.
I';m not using the nice word event -----
Awesome - Everyone is living longer than anticipated because of the DCVAX treatment.
.19 bid ------ .18 Ask
LOL
1 trade at .181 for 5k
Oh Well Always something new
I have 2 shares in two accounts and voted yes to everything.
Don't make me leak but I hope you leak after reading this post.
1indy - That is a great question....
So Is there a Job opening for that position right now???? --- The question remains was that a Permanent position or a Temporary position ??
I don't believe one can find an open rec for that job right now.......
This board can throw that item around for days LOL -- getting all sides.
But I have already made up my mind.
Don't Make Me Leak ---- until Saturday LOL
Repeat Post: Not mind From last November
Al Musella SNO Update
Hi. Just got back from SNO (Society of Neuro-oncology annual meeting). Excellent meeting - overwheling with the amount of information presented. I am going to mention a few of the highlights and welcome others who went to the meeting to post their thoughts.
DCVAX: No updated data was presented but we had a nice meeting with all of the advocacy groups and Northwest bio. They went over the unblinded data that they presented last time and said they will present the final results "soon". I pressed them on that and they said they know but can't tell me. I get the feeling it is going to be pretty good. The longer they wait the better the data will look and it has been a long time.
ABC1212 - Are there any updates on Charlie Ilsley 12 year old boy
.25 - 1.25
This 750,000 took place just like my purchase earlier in the week.
It went off at the bid and immediately the bid and ask move to
.183 to .1909
The trade showed up before the adjustment to the bid and ask
This trade took place between the bid and ask NOT THE BID
Scotty is going to melt away ---
Its so funny Scotty might Make Me Leak Today LOL
Enough of this